Assessing DNA damage and health risk using biomarkers

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 509, Issue 1-2, 2002, Pages 153-163

  Au, William W ^a   Oberheitmann, Boris ^b   Harms, Carsten ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF BREMEN   (Germany)

Author keywords

Benzene; Cancer; Chromosome aberrations; DNA damage; Susceptibility

Indexed keywords

BENZENE; BIOLOGICAL MARKER; CYTOCHROME P450 2E1; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ANEUPLOIDY; ARTICLE; CANCER RISK; CARCINOGENIC ACTIVITY; CHROMOSOME ABERRATION; DISEASE PREDISPOSITION; DNA ADDUCT; DNA DAMAGE; DNA MODIFICATION; DNA STRAND BREAKAGE; GENOTOXICITY; HEALTH HAZARD; HUMAN; LEUKEMIA; METABOLITE; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; TOXICITY TESTING;

ANIMALS; BENZENE; BIOLOGICAL MARKERS; CARCINOGENICITY TESTS; CHO CELLS; CRICETINAE; DNA DAMAGE; ENVIRONMENTAL POLLUTANTS; HUMANS; MICE; MUTAGENICITY TESTS; RISK ASSESSMENT;

ANIMALIA; RODENTIA;

EID: 0037202594     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(02)00226-9     Document Type: Article

References (81)

1. Aksoy M. Hematotoxicity and carcinogenicity of benzene. Environ. Health Perspect. 82:1989;193-197.
2. IARC. Chemicals, Industrial processes and industries associated with cancer in humans, in: IARC (Ed.), IARC Monograph Evaluating Carcinogenic Risk of Chemicals in Humans, 1982 (Suppl. 4), pp. 229-233.
3. A.J. McMichael, Carcinogenicity of benzene, toluene and xylene: Epidemiological and experimental evidence, IARC Sci. Publ. (1988) 3-18.
4. Savitz D.A., Andrews K.W. Review of epidemiologic evidence on benzene and lymphatic and hematopoietic cancers. Am. J. Ind. Med. 31:1997;287-295.
5. Travis L.B., Li C.Y., Zhang Z.N., Li D.G., Yin S.N., Chow W.H., Li G.L., Dosemeci M., Blot W., Fraumeni J.F. Jr. Hematopoietic malignancies and related disorders among benzene-exposed workers in China. Leuk. Lymphoma. 14:1994;91-102.
6. Smith M.T. The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. Environ. Health Perspect. 104(Supp. 6):1996;1219-1225.
7. B.T. Golding, W.P. Watson, Possible mechanisms of carcinogenesis after exposure to benzene, IARC Sci. Publ. (1999) 75-88.
8. Snyder R. Overview of the toxicology of benzene. J. Toxicol. Environ. Health A. 61:2000;339-346.
9. Kalf G.F., Snyder R. A survey of studies on benzene-induced human leukemogenesis: Update on benzene. Adv. Occup. Med. Rehab. 1:1995;39-67.
10. Hayes R.B., Yin S.N., Dosemeci M., Li G.L., Wacholder S., Travis L.B., Li C.Y., Rothman N., Hoover R.N., Linet M.S. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine - National Cancer Institute Benzene Study Group. J. Natl. Cancer Inst. 89:1997;1065-1071.
11. Carere A., Antoccia A., Cimini D., Crebelli R., Degrassi F., Leopardi P., Marcon F., Sgura A., Tanzarella C., Zijno A. Genetic effects of petroleum fuels. II. Analysis of chromosome loss and hyperploidy in peripheral lymphocytes of gasoline station attendants. Environ. Mol. Mutagen. 32:1998;130-138.
12. Smith M.T., Rothman N. Biomarkers in the molecular epidemiology of benzene-exposed workers. J. Toxicol. Environ. Health A. 61:2000;439-445.
13. Smith M.T., Zhang L., Wang Y., Hayes R.B., Li G., Wiemels J., Dosemeci M., Titenko-Holland N., Xi L., Kolachana P., Yin S., Rothman N. Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene. Cancer Res. 58:1998;2176-2181.
14. Tompa A., Major J., Jakab M.G. Monitoring of benzene-exposed workers for genotoxic effects of benzene: improved-working-condition-related decrease in the frequencies of chromosomal aberrations in peripheral blood lymphocytes. Mutat. Res. 304:1994;159-165.
15. Zhang L., Rothman N., Wang Y., Hayes R.B., Yin S., Titenko-Holland N., Dosemeci M., Wang Y.Z., Kolachana P., Lu W., Xi L., Li G.L., Smith M.T. Benzene increases aneuploidy in the lymphocytes of exposed workers: a comparison of data obtained by fluorescence in situ hybridization in interphase and metaphase cells. Environ. Mol. Mutagen. 34:1999;260-268.
16. Forni A. Benzene-induced chromosome aberrations: a follow-up study. Environ. Health Perspect. 104:1996;1309-1312.
17. Zhang L., Eastmond D.A., Smith M.T. The nature of chromosomal aberrations detected in humans exposed to benzene. Crit. Rev. Toxicol. 32:2002;1-42.
18. Forni A.M., Cappellini A., Pacifico E., Vigliani E.C. Chromosome changes and their evolution in subjects with past exposure to benzene. Arch. Environ. Health. 23:1971;385-391.
19. M. Le Beau, Chromosomal abnormalities in hematologic malignant diseases, in: Progress in Clinical and Biological Research: Mutation and the Environment, Wiley, New York, 1990, pp. 325-335.
20. Rothman N., Haas R., Hayes R.B., Li G.L., Wiemels J., Campleman S., Quintana P.J., Xi L.J., Dosemeci M., Titenko-Holland N. Benzene induces gene-duplicating but not gene-inactivating mutations at the glycophorin A locus in exposed humans. Proc. Natl. Acad. Sci. U S A. 92:1995;4069-4073.
21. O'Connor S.R., Farmer P.B., Lauder I. Benzene and non-Hodgkin's lymphoma. J. Pathol. 189:1999;448-453.
22. Nilsson R.I., Nordlinder R.G., Tagesson C., Walles S., Jarvholm B.G. Genotoxic effects in workers exposed to low levels of benzene from gasoline. Am. J. Ind. Med. 30:1996;317-324.
23. Liu L., Zhang Q., Feng J. Urine level of trans, trans-muconic acid used as an index of internal dose of exposure to benzene. Zhonghua Yu Fang Yi Xue Za Zhi. 30:1996;148-150.
24. Liu L., Zhang Q., Feng J., Deng L., Zeng N., Yang A., Zhang W. The study of DNA oxidative damage in benzene-exposed workers. Mutat. Res. 370:1996;145-150.
25. Liu Z.T., Wang L.S., Chen S.P., Li W., Yu H.X. Analysis and prediction of structure-reactive toxicity relationships of substituted aromatic compounds. Bull. Environ. Contam. Toxicol. 57:1996;421-425.
26. Bianchini F., Jaeckel A., Vineis P., Martinez-Garcia C., Elmstahl S., van Kappel A.L., Boeing H., Ohshima H., Riboli E., Kaaks R. Inverse correlation between alcohol consumption and lymphocyte levels of 8-hydroxydeoxyguanosine in humans. Carcinogenesis. 22:2001;885-890.
27. Aksoy M., Dincol K., Akgun T., Erdem S., Dincol G. Haematological effects of chronic benzene poisoning in 217 workers. Br. J. Ind. Med. 28:1971;296-302.
28. Corti M., Snyder C.A. Gender- and age-specific cytotoxic susceptibility to benzene metabolites in vitro. Toxicol. Sci. 41:1998;42-48.
29. Rothman N., Smith M.T., Hayes R.B., Traver R.D., Hoener B., Campleman S., Li G.L., Dosemeci M., Linet M., Zhang L., Xi L., Wacholder S., Lu W., Meyer K.B., Titenko-Holland N., Stewart J.T., Yin S., Ross D. Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C → T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res. 57:1997;2839-2842.
30. Xu X., Wiencke J.K., Niu T., Wang M., Watanabe H., Kelsey K.T., Christiani D.C. Benzene exposure, glutathione S-transferase theta homozygous deletion, and sister chromatid exchanges. Am. J. Ind. Med. 33:1998;157-163.
31. McDonald T.A., Holland N.T., Skibola C., Duramad P., Smith M.T. Hypothesis: phenol and hydroquinone derived mainly from diet and gastrointestinal flora activity are causal factors in leukemia. Leukemia. 15:2001;10-20.
32. Vineis P. Diet, genetic susceptibility and carcinogenesis. Public Health Nutr. 4:2001;485-491.
33. Wang X., Chen D., Niu T., Wang Z., Wang L., Ryan L., Smith T., Christiani D.C., Zuckerman B., Xu A.et al. Genetic susceptibility to benzene and shortened gestation: evidence of gene-environment interaction. Am. J. Epidemiol. 152:2000;693-700.
34. Mazzullo M., Bartoli S., Bonora B., Colacci A., Grilli S., Lattanzi G., Niero A., Turina M.P., Parodi S. Benzene adducts with rat nucleic acids and proteins: dose-response relationship after treatment in vivo. Environ. Health Perspect. 82:1989;259-266.
35. Arfellini G., Grilli S., Colacci A., Mazzullo M., Prodi G. In vivo and in vitro binding of benzene to nucleic acids and proteins of various rat and mouse organs. Cancer Lett. 28:1985;159-168.
36. Sze C.C., Shi C.Y., Ong C.N. Cytotoxicity and DNA strand breaks induced by benzene and its metabolites in Chinese hamster ovary cells. J. Appl. Toxicol. 16:1996;259-264.
37. Bodell W.J., Pathak D.N., Levay G., Ye Q., Pongracz K. Investigation of the DNA adducts formed in B6C3F1 mice treated with benzene: implications for molecular dosimetry. Environ. Health Perspect. 104(Suppl. 6):1996;1189-1193.
38. Kolachana P., Subrahmanyam V.V., Meyer K.B., Zhang L., Smith M.T. Benzene and its phenolic metabolites produce oxidative DNA damage in HL60 cells in vitro and in the bone marrow in vivo. Cancer Res. 53:1993;1023-1026.
39. Hiraku Y., Kawanishi S. Oxidative DNA damage and apoptosis induced by benzene metabolites. Cancer Res. 56:1996;5172-5178.
40. Whysner J. Benzene-induced genotoxicity. J. Toxicol. Environ. Health A. 61:2000;347-351.
41. Joseph P., Klein-Szanto A.J.P., Jaiswal A.K. Hydroquinones cause specific mutations and lead to cellular transformation and in vivo tumorigenesis. Br. J. Cancer. 78:1998;312-320.
42. Li Q., Kasten-Jolly J., Yen Y., Freed B.M. Reversal of hydroquinone-mediated suppression of T cell proliferation by transfection of the M2 subunit of ribonucleotide reductase. Toxicol. Appl. Pharmacol. 150:1998;154-157.
43. Lee E.W., Johnson J.T., Garner C.D. Inhibitory effect of benzene metabolites on nuclear DNA synthesis in bone marrow cells. J. Toxicol. Environ. Health. 26:1989;277-291.
44. Snyder R., Hedli C.C. An Overview of Benzene Metabolism. Environ. Health Perspect. 104:1996;1165-1171.
45. Goldstein B.D. Benzene toxicity. Occup. Med. 3:1988;541-554.
46. Krewski D., Snyder R., Beatty P., Granville G., Meek B., Sonawane B. Assessing the health risks of benzene: a report on the benzene state-of-the-science workshop. J. Toxicol. Environ. Health A. 61:2000;307-338.
47. Sze C.C., Shi C.Y., Ong C.N. Cytotoxicity and DNA strand breaks induced by benzene and its metabolites in Chinese hamster ovary cells. J. Appl. Toxicol. 16:1996;259-264.
48. Baumstark-Khan C., Hentschel U., Nikandrova Y., Krug J., Horneck G. Fluorometric analysis of DNA unwinding (FADU) as a method for detecting repair-induced DNA strand breaks in UV-irradiated mammalian cells. Photochem. Photobiol. 72:2000;477-484.
49. Nakayama A., Koyoshi S., Morisawa S., Yagi T. Comparison of the mutations induced by p-benzoquinone, a benzene metabolite, in human and mouse cells. Mutat. Res.Genet. Toxicol. Environ. Mutagen. 470:2000;147-153.
50. Pfeiffer E., Metzler M. Interaction of p-benzoquinone and p-biphenoquinone with microtubule proteins in vitro. Chem. Biol. Interact. 102:1996;37-53.
51. Hutt A.M., Kalf G.F. Inhibition of human DNA topoisomerase II by hydroquinone and p-benzoquinone, reactive metabolites of benzene. Environ. Health Perspect. 104(Suppl. 6):1996;1265-1269.
52. Gantchev T.G., Hunting D.J. The ortho-quinone metabolite of the anticancer drug etoposide (VP-16) is a potent inhibitor of the topoisomerase II/DNA cleavable complex. Mol. Pharmacol. 53:1998;422-428.
53. Baker R.K., Kurz E.U., Pyatt D.W., Irons R.D., Kroll D.J. Benzene metabolites antagonize etoposide-stabilized cleavable complexes of DNA topoisomerase IIalpha. Blood. 98:2001;830-833.
54. Stark A.A., Rastetter W.H. Structure-activity relationships in the mutagenicity and cytotoxicity of putative metabolites and related analogs of benzene derived from the valence tautomers benzene oxide and oxepin. Environ. Mol. Mutagen. 28:1996;284-293.
55. Bonassi S., Hagmar L., Stromberg U., Montagud A.H., Tinnerberg H., Forni A., Heikkila P., Wanders S., Wilhardt P., Hansteen I.L., Knudsen L.E., Norppa H. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res. 60:2000;1619-1625.
56. Maltoni C., Conti B., Cotti G., Belpoggi F. Experimental studies on benzene carcinogenicity at the Bologna Institute of Oncology: current results and ongoing research. Am. J. Ind. Med. 7:1985;415-446.
57. Maltoni C., Conti B., Scarnato C. Squamous cell carcinomas of the oral cavity in Sprague-Dawley rats, following exposure to benzene by ingestion. First experimental demonstration. Med. Lav. 73:1982;441-445.
58. Snyder C.A., Goldstein B.D., Sellakumar A.R., Albert R.E. Evidence for hematotoxicity and tumorigenesis in rats exposed to 100 ppm benzene. Am. J. Ind. Med. 5:1984;429-434.
59. Snyder C.A., Goldstein B.D., Sellakumar A., Bromberg I., Laskin S., Albert R.E. Toxicity of chronic benzene inhalation: CD-1 mice exposed to 300 ppm. Bull. Environ. Contam. Toxicol. 29:1982;385-391.
60. Baarson K.A., Snyder C.A., Green J.D., Sellakumar A., Goldstein B.D., Albert R.E. The hematotoxic effects of inhaled benzene on peripheral blood, bone marrow, and spleen cells are increased by ingested ethanol. Toxicol. Appl. Pharmacol. 64:1982;393-404.
61. Snyder C.A., Goldstein B.D., Sellakumar A.R., Bromberg I., Laskin S., Albert R.E. The inhalation toxicology of benzene: incidence of hematopoietic neoplasms and hematotoxicity in ARK/J and C57BL/6J mice. Toxicol. Appl. Pharmacol. 54:1980;323-331.
62. Cronkite E.P., Drew R.T., Inoue T., Hirabayashi Y., Bullis J.E. Hematotoxicity and carcinogenicity of inhaled benzene. Environ. Health Perspect. 82:1989;97-108.
63. Cronkite E.P., Drew R.T., Inoue T., Bullis J.E. Benzene hematotoxicity and leukemogenesis. Am. J. Ind. Med. 7:1985;447-456.
64. Cronkite E.P., Bullis J., Inoue T., Drew R.T. Benzene inhalation produces leukemia in mice. Toxicol. Appl. Pharmacol. 75:1984;358-361.
65. Cronkite E.P., Inoue T., Carsten A.L., Miller M.E., Bullis J.E., Drew R.T. Effects of benzene inhalation on murine pluripotent stem cells. J. Toxicol. Environ. Health. 9:1982;411-421.
66. Snyder C.A., Sellakumar A.R., James D.J., Albert R.E. The carcinogenicity of discontinuous inhaled benzene exposures in CD-1 and C57Bl/6 mice. Arch. Toxicol. 62:1988;331-335.
67. Maltoni C., Conti B., Perino G., Di M. Further evidence of benzene carcinogenicity. Results on Wistar rats and Swiss mice treated by ingestion. Ann. N.Y. Acad. Sci. 534:1988;412-426.
68. Busby W.F. Jr., Wang J.S., Stevens E.K., Padykula R.E., Aleksejczyk R.A., Berchtold G.A. Lung tumorigenicity of benzene oxide, benzene dihydrodiols and benzene diolepoxides in the BLU:Ha newborn mouse assay. Carcinogenesis. 11:1990;1473-1478.
69. Farris G.M., Everitt J.I., Irons R.D., Popp J.A. Carcinogenicity of inhaled benzene in CBA mice. Fundam. Appl. Toxicol. 20:1993;503-507.
70. Maltoni C., Ciliberti A., Carretti D. Experimental contributions in identifying brain potential carcinogens in the petrochemical industry. Ann. N.Y. Acad. Sci. 381:1982;216-249.
71. Storer R.D., Cartwright M.E., Cook W.O., Soper K.A., Nichols W.W. Short-term carcinogenesis bioassay of genotoxic procarcinogens in PIM transgenic mice. Carcinogenesis. 16:1995;285-293.
72. Snyder C.A., Goldstein B.D., Sellakumar A.R., Bromberg I., Laskin S., Albert R.E. The inhalation toxicology of benzene: incidence of hematopoietic neoplasms and hematotoxicity in ARK/J and C57BL/6J mice. Toxicol. Appl. Pharmacol. 54:1980;323-331.
73. Maltoni C., Scarnato C. First experimental demonstration of the carcinogenic effects of benzene long-term bioassays on Sprague-Dawley rats by oral administration. Med. Lav. 70:1979;352-357.
74. Cronkite E.P., Drew R.T., Inoue T., Hirabayashi Y., Bullis J.E. Hematotoxicity and carcinogenicity of inhaled benzene. Environ. Health Perspect. 82:1989;97-108.
75. Snyder C.A., Sellakumar A.R., James D.J., Albert R.E. The carcinogenicity of discontinuous inhaled benzene exposures in CD-1 and C57Bl/6 mice. Arch. Toxicol. 62:1988;331-335.
76. Goldstein B.D., Snyder C.A., Laskin S., Bromberg I., Albert R.E., Nelson N. Myelogenous leukemia in rodents inhaling benzene. Toxicol. Lett. 13:1982;169-173.
77. Savitz D.A., Andrews K.W. Review of epidemiologic evidence on benzene and lymphatic and hematopoietic cancers. Am. J. Ind. Med. 31:1997;287-295.
78. Yin S.N., Hayes R.B., Linet M.S., Li G.L., Dosemeci M., Travis L.B., Zhang Z.N., Li D.G., Chow W.H., Wacholder S., Blot W.J. An expanded cohort study of cancer among benzene-exposed workers in China. Benzene Study Group. Environ. Health Perspect. 104(Suppl. 6):1996;1339-1341.
79. Loeb L.A. A mutator phenotype in cancer. Cancer Res. 61:2001;3230-3239.
80. Agency for Toxic Substances and Disease Registry, Toxicological Profile for Benzene, Department of Health and Human Services, Public Health Services, USA, 2001.
81. Vineis P., McMichael A.J. Bias and confounding in molecular epidemiological studies: special considerations. Carcinogenesis. 19:1998;2063-2067.